![]() ![]() ![]() Recommendation may change when higher quality evidence becomes available further research (if performed) is likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Recommendation can apply to most patients in most circumstances further research (if performed) is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.Įvidence for ≥1 critical outcome from observational studies, RCTs with serious flaws or indirect evidence Recommendation can apply to most patients in most circumstances further research is unlikely to change our confidence in the estimate of effect.Įvidence from RCTs with important limitations (inconsistent results, methodologic flaws, indirect, or imprecise) or exceptionally strong evidence from unbiased observational studies Methodologic quality of supporting evidence (examples)ĭesirable effects clearly outweigh undesirable effects, or vice versaĬonsistent evidence from well-performed RCTs a or exceptionally strong evidence from unbiased observational studies Strength of recommendation and quality of evidenceĬlarity of balance between desirable and undesirable effects A detailed description of the methods, background, and evidence summaries that support each of the recommendations can be found in the full text of the guidelines. ![]() The panel followed a process used in the development of other Infectious Diseases Society of America (IDSA) guidelines, which included a systematic weighting of the quality of the evidence and the grade of the recommendation ( Table 1). Summarized below are the recommendations made in the new 2011 pediatric CAP guidelines. Management of neonates and young infants through the first 3 months, immunocompromised children, children receiving home mechanical ventilation, and children with chronic conditions or underlying lung disease, such as cystic fibrosis, are beyond the scope of these guidelines and are not discussed. This document is designed to provide guidance in the care of otherwise healthy infants and children and addresses practical questions of diagnosis and management of CAP evaluated in outpatient (offices, urgent care clinics, emergency departments) or inpatient settings in the United States. The goal of these guidelines is to decrease morbidity and mortality rates for CAP in children by presenting recommendations for clinical management that can be applied in individual cases if deemed appropriate by the treating clinician. They do not represent the only approach to diagnosis and therapy there is considerable variation among children in the clinical course of pediatric CAP, even with infection caused by the same pathogen. These guidelines were created to assist the clinician in the care of a child with CAP. Guidelines for the management of community-acquired pneumonia (CAP) in adults have been demonstrated to decrease morbidity and mortality rates. ![]()
0 Comments
Leave a Reply. |